New Insights in Anti-Angiogenesis in Multiple Myeloma
- PMID: 30002349
- PMCID: PMC6073492
- DOI: 10.3390/ijms19072031
New Insights in Anti-Angiogenesis in Multiple Myeloma
Abstract
Angiogenesis is a constant hallmark of multiple myeloma (MM) progression and involves direct production of angiogenic cytokines by plasma cells and their induction within the bone marrow microenvironment. This article summarizes the more recent literature data concerning the employment of anti-angiogenic therapeutic agents actually used in preclinical models and clinical settings for the treatment of multiple myeloma.
Keywords: angiogenesis; anti-angiogenesis; multiple myeloma; tumor growth.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M.G., Pe’er J., Trent J.M., Meltzer P.S., Hendrix M.J.C. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am. J. Pathol. 1999;155:739–752. doi: 10.1016/S0002-9440(10)65173-5. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
